Introduction
Overjet is a dental AI company founded in 2018 in Boston by Wardah Inam. It built its reputation on FDA-cleared artificial intelligence that analyzes dental radiographs — detecting and quantifying conditions such as caries, bone loss, and anatomical structures with consistency that supports both clinical care and payer claims review. Dentistry has historically relied on visual radiograph interpretation with significant inter-provider variability; Overjet’s pitch is that AI can standardize those readouts and surface findings that busy clinicians might miss in high-volume practices.
On January 28, 2026, Overjet announced general availability of Overjet Voice, expanding from imaging AI into AI-powered clinical documentation — including automated periodontal charting, voice notes, and referral letters. Brel did not retain the CSV’s Copilot product claim because that attribution could not be verified against company sources.
Dental AI adoption has lagged hospital radiology partly because dental practices are fragmented and reimbursement differs from medical CPT pathways — Overjet’s payer-side business partially offsets that fragmentation by creating demand from insurers, not only from individual dentists.
What the company does
Overjet’s Clinical Intelligence Platform combines AI radiograph analysis with workflow tools for dental providers and, increasingly, documentation automation through Overjet Voice. The imaging layer overlays AI detections on bitewing and panoramic radiographs, giving dentists a second read aligned with FDA-cleared indications. The voice layer addresses a separate pain point: administrative documentation time that reduces chair-side patient care. Overjet sells to individual practices and to dental service organizations that need standardized AI across dozens or hundreds of locations.
Who it serves
Overjet serves dental providers who want AI-assisted radiograph review integrated into daily operatory workflow, and dental payers that use Overjet’s technology for claims analysis and utilization review. DSOs — multi-site dental groups — represent a significant customer segment because they benefit from standardized AI readouts across geographically dispersed practices. Overjet Voice targets the same customer base with documentation automation, appealing to practice owners measuring labor cost per visit and hygienist charting burden.
Wardah Inam’s founding vision centered on measurable clinical and operational outcomes in dentistry rather than generic AI tooling — a positioning that aligns with FDA-cleared imaging as the company’s anchor product.
Company background
Wardah Inam founded Overjet in 2018 in Boston, bringing a background in AI and healthcare technology to a dental market that had seen less AI adoption than hospital radiology. The company pursued FDA clearance for its imaging algorithms — a regulatory step that distinguishes serious clinical AI vendors from consumer dental apps. Overjet expanded from provider-side clinical tools into payer partnerships, reflecting dentistry’s unique two-sided market where insurers and providers both influence technology adoption.
Boston’s health-tech talent pool and proximity to dental insurance and DSO headquarters made it a natural base for a company selling simultaneously to clinical practices and payer analytics teams — a dual go-to-market that shapes Overjet’s product roadmap toward both chair-side imaging and claims-level consistency.
Product and AI capabilities
Overjet’s core imaging AI uses computer vision on dental radiographs, trained on large annotated datasets of caries, bone levels, and anatomical landmarks. Overjet Voice, made generally available on January 28, 2026, applies speech recognition and generative documentation techniques to dental operatory workflows — automating perio charting, generating visit summaries, and drafting referral correspondence from clinician speech. Overjet describes Voice as part of a unified clinical intelligence suite connecting diagnosis, documentation, and practice performance, per its January 2026 company announcement.
Voice AI in dentistry faces distinct privacy and workflow constraints compared with physician ambient documentation: operatory noise, hygienist handoffs, and dental-specific charting fields require models tuned to dental vocabulary rather than general medical scribes.
Key developments
2018: Overjet founded in Boston by Wardah Inam. January 28, 2026: General availability of Overjet Voice announced on Overjet’s company blog. CSV Copilot integration claim removed as unverified.
Overjet Voice extends a product line that began with FDA-cleared imaging AI, showing how dental AI vendors are bundling diagnostic and documentation capabilities into unified operatory software rather than selling point tools separately.
Why it matters
Overjet matters because dental care is a large, fragmented clinical market where AI adoption lagged hospital specialties — and because Overjet Voice shows dental AI moving beyond static image analysis into ambient documentation, mirroring trends in physician ambient AI exemplified by companies such as Suki AI. The January 2026 Voice release is a dated, verifiable product milestone. Overjet also illustrates how FDA clearance and payer relationships create moats in dental AI that general-purpose vision models cannot easily replicate without clinical validation work.
Sector context
Overjet belongs in Brel’s AI in healthcare coverage under dental — a distinct subsector with different reimbursement, regulatory, and practice structure than hospital clinical AI. Related ambient documentation profiles include Suki AI (physician EHR integration). Hospital imaging and cardiology companies such as Butterfly Network operate on different clinical economics.
Sources and references
Overjet general-availability announcement (January 28, 2026) and company website.
- Overjet — General availability of Overjet Voice (overjet.com, January 28, 2026)
- Overjet — Company website (overjet.ai)